The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis

被引:57
作者
Prasse, Antje [1 ,2 ,3 ]
机构
[1] Hannover Med Sch, Clin Pneumol, Hannover, Germany
[2] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany
[3] DZL BREATH, German Ctr Lung Res, Hannover, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 33-34期
关键词
PULMONARY SARCOIDOSIS; CARDIAC SARCOIDOSIS; INFLIXIMAB; THERAPY; MANIFESTATIONS; EPIDEMIOLOGY; INVOLVEMENT; MORTALITY; SEVERITY; FIBROSIS;
D O I
10.3238/arztebl.2016.0565
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Sarcoidosis is a granulomatous inflammatory disease of unknown cause. Its prevalence in Germany is approximately 46 per 100 000 persons. Methods: This article is based on pertinent publications retrieved by a selective search in PubMed. Results: A presumptive diagnosis of sarcoidosis is made in any patient with a granulomatous inflammation that is not explained by any other identifiable cause, such as an infection or foreign body. Non-caseating granulomas containing epithelioid cells are its histological hallmark. Recently developed diagnostic techniques, including positron emission tomography and magnetic resonance imaging, have made it easier to detect organ involvement and to assess the activity of the disease. The pattern of organ involvement varies from patient to patient. Many patients have a systemic inflammatory reaction with sub-febrile or febrile temperatures, night sweats, weight loss, diminished physical reserve, and fatigue. Sarcoidosis often resolves spontaneously. Detection of organ involvement is not necessarily an indication for treatment, but treatment is clearly needed if there is symptomatic cardiac involvement or any involvement of the central nervous system. Oral corticosteroids are the first line of treatment. Their long-term use can cause serious complications. Conclusion: The treatment of patients with sarcoidosis, particularly those with complicated disease courses, requires close collaboration of the primary care physician with a specialized interdisciplinary center.
引用
收藏
页码:565 / +
页数:11
相关论文
共 65 条
[1]   Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: A systematic review and meta-analysis [J].
Agarwal, Ritesh ;
Srinivasan, Arjun ;
Aggarwal, Ashutosh N. ;
Gupta, Dheeraj .
RESPIRATORY MEDICINE, 2012, 106 (06) :883-892
[2]   Advances in imaging for diagnosis and management of cardiac sarcoidosis [J].
Aggarwal, Niti R. ;
Snipelisky, David ;
Young, Phillip M. ;
Gersh, Bernard J. ;
Cooper, Leslie T. ;
Chareonthaitawee, Panithaya .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2015, 16 (09) :949-958
[3]  
[Anonymous], 1999, Am J Respir Crit Care Med, V160, P736
[4]   Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies [J].
Bagwan, Izhar N. ;
Hooper, Lucy V. B. ;
Sheppard, Mary N. .
VIRCHOWS ARCHIV, 2011, 458 (06) :671-678
[5]  
Baughman RP, 2013, SARCOIDOSIS VASC DIF, V30, P113
[6]   Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement [J].
Baughman, Robert P. ;
Drent, Marjolein ;
Kavuru, Mani ;
Judson, Marc A. ;
Costabel, Ulrich ;
du Bois, Roland ;
Albera, Carlo ;
Brutsche, Martin ;
Davis, Gerald ;
Donohue, James F. ;
Mueller-Quernheim, Joachim ;
Schlenker-Herceg, Rozsa ;
Flavin, Susan ;
Lo, Kim Hung ;
Oemar, Barry ;
Barnathan, Elliot S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) :795-802
[7]  
Baughman RP, 2015, SARCOIDOSIS VASC DIF, V32, P289
[8]   New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches [J].
Baughman, Robert P. ;
Grutters, Jan C. .
LANCET RESPIRATORY MEDICINE, 2015, 3 (10) :813-822
[9]   Relapses of sarcoidosis: what are they and can we predict who will get them? [J].
Baughman, Robert P. ;
Judson, Marc A. .
EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (02) :337-339
[10]   Who Dies from Sarcoidosis and Why? [J].
Baughman, Robert P. ;
Lower, Elyse E. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (11) :1446-1447